EGFR-IL12-CART Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EGFR-IL12-CART Cells, covering 2018-05-31 to 2018-05-31. Get the full timeline:
Most recent: Clinical Trial Update: EGFR-IL12-CART Cells for Patients With Metastatic Colorectal Cancer [Phase 1]